Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Oncotarget|April 23, 2019
Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progressionJian Ma, Yanxin Fan, Tingting Feng, et al.
Cellular Immunology|May 13, 2021
Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancerShiyao Du, Huizi Sha, Naiqing Ding, et al.
Oncotarget|May 30, 2018
Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progressionJian Ma, Yanxin Fan, Tingting Feng, et al.
Oncotarget|November 22, 2017
HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progressionJian Ma, Yanxin Fan, Tingting Feng, et al.
International Journal of Nanomedicine|September 27, 2018
Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant proteinHong Chen, Huizi Sha, Lianru Zhang, et al.
American Journal of Cancer Research|February 9, 2018
Bispecific tumor-penetrating protein anti-EGFR-iRGD efficiently enhances the infiltration of lymphocytes in gastric cancerAnqing Zhu, Huizi Sha, Shu Su, et al.
Nature Communications|March 24, 2019
iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancerNaiqing Ding, Zhengyun Zou, Huizi Sha, et al.
Oncoimmunology|February 16, 2017
CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancerShu Su, Zhengyun Zou, Fangjun Chen, et al.
Scientific Reports|January 29, 2016
CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patientsShu Su, Bian Hu, Jie Shao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 9, 2022
Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High-Risk Gastric/Gastroesophageal Junction CancerQin Liu, Yanhong Chu, Jie Shao, et al.
Pageof 7